Swedish Cancer Institute is a clinical research site located in Seattle, Washington, United States 98104.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
Swedish Cancer Institute has participated in 285 clinical trials with 78 currently active.
Therapeutic areas: HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.
Sponsors: Seagen Inc., Adaptive Biotechnologies, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Seattle
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Swedish Cancer Institute has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Swedish Cancer Institute has 285 clinical trials on record, with 78 currently active. Their work covers HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.
Swedish Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.